The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024. Popular drugs like Escitalopram, Clonazepam, and Sertraline saw significant ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.
Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.
Both drugs were given on top of standard antidepressants to patients wo had ... and the company will look to the new data to try to encourage take-up. One issue has been the cost of the drug ...
The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...